Lamea Oncology/Anti-Cancer Drugs Market Report

China Lamea Oncology/Anti-Cancer Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Sep 06, 2023
  • PAGES：152
  • REPORT CODE：GMM1780178
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Lamea Oncology/Anti-Cancer Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Amgen

    • AstraZeneca

    • Roche Diagnostics

    • Sanofi

    • Novartis

    • AbbVie

    • EIMC United Pharmaceuticals

    • Actavis plc

    • GlaxoSmithKline

    By Type:

    • Injectable Therapy

    • Oral Therapy

    By Application:

    • Others

    • Chemotherapy

    • Targeted Therapy

    • Immunotherapy (Biologic Therapy)

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Lamea Oncology/Anti-Cancer Drugs Market Overview 2018-2029

    • 1.1 China Lamea Oncology/Anti-Cancer Drugs Industry Development Overview

    • 1.2 China Lamea Oncology/Anti-Cancer Drugs Industry Development History

    • 1.3 China Lamea Oncology/Anti-Cancer Drugs Industry Market Size (2018-2029)

    • 1.4 China Lamea Oncology/Anti-Cancer Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Lamea Oncology/Anti-Cancer Drugs Production Volume, Production Value and Growth Rate of Injectable Therapy (2018-2029)

      • 1.4.2 China Lamea Oncology/Anti-Cancer Drugs Production Volume, Production Value and Growth Rate of Oral Therapy (2018-2029)

    • 1.5 China Lamea Oncology/Anti-Cancer Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Lamea Oncology/Anti-Cancer Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.2 China Lamea Oncology/Anti-Cancer Drugs Sales Volume, Sales Value and Growth Rate of Chemotherapy (2018-2029)

      • 1.5.3 China Lamea Oncology/Anti-Cancer Drugs Sales Volume, Sales Value and Growth Rate of Targeted Therapy (2018-2029)

      • 1.5.4 China Lamea Oncology/Anti-Cancer Drugs Sales Volume, Sales Value and Growth Rate of Immunotherapy (Biologic Therapy) (2018-2029)

    • 1.6 China Lamea Oncology/Anti-Cancer Drugs Market Analysis by Region

      • 1.6.1 North China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Lamea Oncology/Anti-Cancer Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Lamea Oncology/Anti-Cancer Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Lamea Oncology/Anti-Cancer Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Lamea Oncology/Anti-Cancer Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Lamea Oncology/Anti-Cancer Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Lamea Oncology/Anti-Cancer Drugs Industry Development

    Chapter 3 Lamea Oncology/Anti-Cancer DrugsIndustry Chain Analysis

    • 3.1 Lamea Oncology/Anti-Cancer Drugs Industry Chain

    • 3.2 Lamea Oncology/Anti-Cancer Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Lamea Oncology/Anti-Cancer Drugs Market

    • 3.3 Lamea Oncology/Anti-Cancer Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Lamea Oncology/Anti-Cancer Drugs Market

    Chapter 4 China Lamea Oncology/Anti-Cancer Drugs Market, by Type

    • 4.1 China Lamea Oncology/Anti-Cancer Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Lamea Oncology/Anti-Cancer Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Lamea Oncology/Anti-Cancer Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Lamea Oncology/Anti-Cancer Drugs Production Volume and Growth Rate of Injectable Therapy

      • 4.5.2 China Lamea Oncology/Anti-Cancer Drugs Production Volume and Growth Rate of Oral Therapy

    Chapter 5 China Lamea Oncology/Anti-Cancer Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Lamea Oncology/Anti-Cancer Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate of Others

      • 5.5.2 China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate of Chemotherapy

      • 5.5.3 China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate of Targeted Therapy

      • 5.5.4 China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate of Immunotherapy (Biologic Therapy)

    Chapter 6 China Lamea Oncology/Anti-Cancer Drugs Market, by Region

    • 6.1 China Lamea Oncology/Anti-Cancer Drugs Production Volume and Production Value, by Region

    • 6.2 China Lamea Oncology/Anti-Cancer Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Lamea Oncology/Anti-Cancer Drugs Market Analysis

    • 7.1 North China Lamea Oncology/Anti-Cancer Drugs Market, by Type

    • 7.2 North China Lamea Oncology/Anti-Cancer Drugs Market, by Application

    Chapter 8 Central China Lamea Oncology/Anti-Cancer Drugs Market Analysis

    • 8.1 Central China Lamea Oncology/Anti-Cancer Drugs Market, by Type

    • 8.2 Central China Lamea Oncology/Anti-Cancer Drugs Market, by Application

    Chapter 9 South China Lamea Oncology/Anti-Cancer Drugs Market Analysis

    • 9.1 South China Lamea Oncology/Anti-Cancer Drugs Market, by Type

    • 9.2 South China Lamea Oncology/Anti-Cancer Drugs Market, by Application

    Chapter 10 East China Lamea Oncology/Anti-Cancer Drugs Market Analysis

    • 10.1 East China Lamea Oncology/Anti-Cancer Drugs Market, by Type

    • 10.2 East China Lamea Oncology/Anti-Cancer Drugs Market, by Application

    Chapter 11 Northeast China Lamea Oncology/Anti-Cancer Drugs Market Analysis

    • 11.1 Northeast China Lamea Oncology/Anti-Cancer Drugs Market, by Type

    • 11.2 Northeast China Lamea Oncology/Anti-Cancer Drugs Market, by Application

    Chapter 12 Southwest China Lamea Oncology/Anti-Cancer Drugs Market Analysis

    • 12.1 Southwest China Lamea Oncology/Anti-Cancer Drugs Market, by Type

    • 12.2 Southwest China Lamea Oncology/Anti-Cancer Drugs Market, by Application

    Chapter 13 Northwest China Lamea Oncology/Anti-Cancer Drugs Market Analysis

    • 13.1 Northwest China Lamea Oncology/Anti-Cancer Drugs Market, by Type

    • 13.2 Northwest China Lamea Oncology/Anti-Cancer Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Amgen

        • 14.1.1 Amgen Company Profile

        • 14.1.2 Amgen Lamea Oncology/Anti-Cancer Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 AstraZeneca

        • 14.2.1 AstraZeneca Company Profile

        • 14.2.2 AstraZeneca Lamea Oncology/Anti-Cancer Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Roche Diagnostics

        • 14.3.1 Roche Diagnostics Company Profile

        • 14.3.2 Roche Diagnostics Lamea Oncology/Anti-Cancer Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Sanofi

        • 14.4.1 Sanofi Company Profile

        • 14.4.2 Sanofi Lamea Oncology/Anti-Cancer Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Novartis

        • 14.5.1 Novartis Company Profile

        • 14.5.2 Novartis Lamea Oncology/Anti-Cancer Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 AbbVie

        • 14.6.1 AbbVie Company Profile

        • 14.6.2 AbbVie Lamea Oncology/Anti-Cancer Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 EIMC United Pharmaceuticals

        • 14.7.1 EIMC United Pharmaceuticals Company Profile

        • 14.7.2 EIMC United Pharmaceuticals Lamea Oncology/Anti-Cancer Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Actavis plc

        • 14.8.1 Actavis plc Company Profile

        • 14.8.2 Actavis plc Lamea Oncology/Anti-Cancer Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 GlaxoSmithKline

        • 14.9.1 GlaxoSmithKline Company Profile

        • 14.9.2 GlaxoSmithKline Lamea Oncology/Anti-Cancer Drugs Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Lamea Oncology/Anti-Cancer Drugs Industry Research Conclusions

    • 15.2 Lamea Oncology/Anti-Cancer Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Lamea Oncology/Anti-Cancer Drugs Industry Market Size (2018-2029)

    • Figure China Lamea Oncology/Anti-Cancer Drugs Production Volume, Production Value and Growth Rate of Injectable Therapy (2018-2029)

    • Figure China Lamea Oncology/Anti-Cancer Drugs Production Volume, Production Value and Growth Rate of Oral Therapy (2018-2029)

    • Figure China Lamea Oncology/Anti-Cancer Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Lamea Oncology/Anti-Cancer Drugs Sales Volume, Sales Value and Growth Rate of Chemotherapy (2018-2029)

    • Figure China Lamea Oncology/Anti-Cancer Drugs Sales Volume, Sales Value and Growth Rate of Targeted Therapy (2018-2029)

    • Figure China Lamea Oncology/Anti-Cancer Drugs Sales Volume, Sales Value and Growth Rate of Immunotherapy (Biologic Therapy) (2018-2029)

    • Figure North China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure Lamea Oncology/Anti-Cancer Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Lamea Oncology/Anti-Cancer Drugs Market Share by Type in 2018

    • Figure China Lamea Oncology/Anti-Cancer Drugs Market Share by Type in 2023

    • Figure China Lamea Oncology/Anti-Cancer Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Lamea Oncology/Anti-Cancer Drugs Production Volume and Growth Rate of Injectable Therapy (2018-2023)

    • Figure China Lamea Oncology/Anti-Cancer Drugs Production Volume and Growth Rate of Oral Therapy (2018-2023)

    • Figure China Lamea Oncology/Anti-Cancer Drugs Market Share by Application in 2018

    • Figure China Lamea Oncology/Anti-Cancer Drugs Market Share by Application in 2023

    • Figure China Lamea Oncology/Anti-Cancer Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate of Others (2018-2023)

    • Figure China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate of Chemotherapy (2018-2023)

    • Figure China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate of Targeted Therapy (2018-2023)

    • Figure China Lamea Oncology/Anti-Cancer Drugs Market Size and Growth Rate of Immunotherapy (Biologic Therapy) (2018-2023)

    • Table China Lamea Oncology/Anti-Cancer Drugs Production Volume by Region (2018-2023)

    • Table China Lamea Oncology/Anti-Cancer Drugs Production Volume Share by Region (2018-2023)

    • Figure China Lamea Oncology/Anti-Cancer Drugs Production Volume Share by Region (2018-2023)

    • Table China Lamea Oncology/Anti-Cancer Drugs Production Value by Region (2018-2023)

    • Table China Lamea Oncology/Anti-Cancer Drugs Production Value Share by Region (2018-2023)

    • Figure China Lamea Oncology/Anti-Cancer Drugs Production Value Share by Region (2018-2023)

    • Table China Lamea Oncology/Anti-Cancer Drugs Sales Volume by Region (2018-2023)

    • Table China Lamea Oncology/Anti-Cancer Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Lamea Oncology/Anti-Cancer Drugs Sales Volume Share by Region (2018-2023)

    • Table China Lamea Oncology/Anti-Cancer Drugs Sales Value by Region (2018-2023)

    • Table China Lamea Oncology/Anti-Cancer Drugs Sales Value Share by Region (2018-2023)

    • Figure China Lamea Oncology/Anti-Cancer Drugs Sales Value Share by Region (2018-2023)

    • Table North China Lamea Oncology/Anti-Cancer Drugs Production Volume by Type (2018-2023)

    • Table North China Lamea Oncology/Anti-Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Lamea Oncology/Anti-Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table North China Lamea Oncology/Anti-Cancer Drugs Sales Volume by Application (2018-2023)

    • Table North China Lamea Oncology/Anti-Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Lamea Oncology/Anti-Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Lamea Oncology/Anti-Cancer Drugs Production Volume by Type (2018-2023)

    • Table Central China Lamea Oncology/Anti-Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Lamea Oncology/Anti-Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Lamea Oncology/Anti-Cancer Drugs Sales Volume by Application (2018-2023)

    • Table Central China Lamea Oncology/Anti-Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Lamea Oncology/Anti-Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Lamea Oncology/Anti-Cancer Drugs Production Volume by Type (2018-2023)

    • Table South China Lamea Oncology/Anti-Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Lamea Oncology/Anti-Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table South China Lamea Oncology/Anti-Cancer Drugs Sales Volume by Application (2018-2023)

    • Table South China Lamea Oncology/Anti-Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Lamea Oncology/Anti-Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Lamea Oncology/Anti-Cancer Drugs Production Volume by Type (2018-2023)

    • Table East China Lamea Oncology/Anti-Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Lamea Oncology/Anti-Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table East China Lamea Oncology/Anti-Cancer Drugs Sales Volume by Application (2018-2023)

    • Table East China Lamea Oncology/Anti-Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Lamea Oncology/Anti-Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Lamea Oncology/Anti-Cancer Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Lamea Oncology/Anti-Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Lamea Oncology/Anti-Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Lamea Oncology/Anti-Cancer Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Lamea Oncology/Anti-Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Lamea Oncology/Anti-Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Lamea Oncology/Anti-Cancer Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Lamea Oncology/Anti-Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Lamea Oncology/Anti-Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Lamea Oncology/Anti-Cancer Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Lamea Oncology/Anti-Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Lamea Oncology/Anti-Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Lamea Oncology/Anti-Cancer Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Lamea Oncology/Anti-Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Lamea Oncology/Anti-Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Lamea Oncology/Anti-Cancer Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Lamea Oncology/Anti-Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Lamea Oncology/Anti-Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Lamea Oncology/Anti-Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Lamea Oncology/Anti-Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Roche Diagnostics Company Profile

    • Table Roche Diagnostics Lamea Oncology/Anti-Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Lamea Oncology/Anti-Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Lamea Oncology/Anti-Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table AbbVie Company Profile

    • Table AbbVie Lamea Oncology/Anti-Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table EIMC United Pharmaceuticals Company Profile

    • Table EIMC United Pharmaceuticals Lamea Oncology/Anti-Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Actavis plc Company Profile

    • Table Actavis plc Lamea Oncology/Anti-Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Lamea Oncology/Anti-Cancer Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US